Lixte Biotechnology Holdings, I
Q4 2022 13F Holders
Symbol
LIXT
CUSIP
539319202
Type
Equity
Class
COM
Num filings
17
Total reported value, excl. options
$379 k
Compare 2022 Q4 to
2023 Q2
2023 Q1
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q4
Manager
Report Date
Value ($000)
Shares
Option Type